Skip to Content

3.75 WATSON 363 (Clorazepate Dipotassium 3.75 mg)

Pill with imprint 3.75 WATSON 363 is Blue, Round and has been identified as Clorazepate Dipotassium 3.75 mg. It is supplied by Watson Pharmaceuticals.

Clorazepate is used in the treatment of anxiety; seizure prevention; alcohol withdrawal and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 3.75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for 3.75 WATSON 363

Clorazepate Dipotassium

Imprint
3.75 WATSON 363
Strength
3.75 mg
Color
Blue
Shape
Round
Availability
Prescription only
Drug Class
Benzodiazepines
Pregnancy Category
N - Not classified
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-0363

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.